RU93050068A - CYCLOPEPTIDES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND METHOD OF THEIR PRODUCTION, METHOD OF TREATMENT - Google Patents
CYCLOPEPTIDES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND METHOD OF THEIR PRODUCTION, METHOD OF TREATMENTInfo
- Publication number
- RU93050068A RU93050068A RU93050068/04A RU93050068A RU93050068A RU 93050068 A RU93050068 A RU 93050068A RU 93050068/04 A RU93050068/04 A RU 93050068/04A RU 93050068 A RU93050068 A RU 93050068A RU 93050068 A RU93050068 A RU 93050068A
- Authority
- RU
- Russia
- Prior art keywords
- production
- treatment
- cyclopeptides
- asp
- pharmaceutical compositions
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title claims 2
- 108010069514 Cyclic Peptides Proteins 0.000 title claims 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 claims 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N L-serine Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 102000006495 integrins Human genes 0.000 claims 1
- 108010044426 integrins Proteins 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4237456A DE4237456A1 (en) | 1992-11-06 | 1992-11-06 | cyclopeptides |
DEP4237456.1 | 1992-11-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93050068A true RU93050068A (en) | 1996-04-27 |
RU2129563C1 RU2129563C1 (en) | 1999-04-27 |
Family
ID=6472232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93050068A RU2129563C1 (en) | 1992-11-06 | 1993-11-04 | Cyclopeptides of salts thereof, method of preparation thereof, pharmaceutical compositions, method of preparing thereof, and method of treatment |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0596350B1 (en) |
JP (1) | JP3681764B2 (en) |
KR (1) | KR100238894B1 (en) |
CN (1) | CN1038751C (en) |
AT (1) | ATE154037T1 (en) |
AU (1) | AU666586B2 (en) |
CA (1) | CA2102447C (en) |
CZ (1) | CZ286170B6 (en) |
DE (2) | DE4237456A1 (en) |
DK (1) | DK0596350T3 (en) |
ES (1) | ES2105041T3 (en) |
GR (1) | GR3024550T3 (en) |
HU (1) | HU215600B (en) |
MX (1) | MX9306885A (en) |
NO (1) | NO309864B1 (en) |
PL (1) | PL177772B1 (en) |
RU (1) | RU2129563C1 (en) |
SK (1) | SK280597B6 (en) |
TW (1) | TW340849B (en) |
UA (1) | UA43822C2 (en) |
ZA (1) | ZA938281B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111372586B (en) * | 2017-11-20 | 2023-07-25 | 诺麦塔制药有限公司 | Composition for preventing, improving or treating bone loss diseases comprising CHP |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816449A (en) * | 1984-08-09 | 1989-03-28 | Immunetech Pharmaceuticals | Immunotherapeutic anti-inflammatory peptide agents |
-
1992
- 1992-11-06 DE DE4237456A patent/DE4237456A1/en not_active Withdrawn
-
1993
- 1993-10-23 AT AT93117204T patent/ATE154037T1/en active
- 1993-10-23 DE DE59306654T patent/DE59306654D1/en not_active Expired - Lifetime
- 1993-10-23 DK DK93117204.3T patent/DK0596350T3/en active
- 1993-10-23 ES ES93117204T patent/ES2105041T3/en not_active Expired - Lifetime
- 1993-10-23 EP EP93117204A patent/EP0596350B1/en not_active Expired - Lifetime
- 1993-10-29 KR KR1019930022666A patent/KR100238894B1/en not_active IP Right Cessation
- 1993-10-29 UA UA93002450A patent/UA43822C2/en unknown
- 1993-11-01 AU AU50399/93A patent/AU666586B2/en not_active Expired
- 1993-11-02 SK SK1217-93A patent/SK280597B6/en not_active IP Right Cessation
- 1993-11-04 RU RU93050068A patent/RU2129563C1/en active
- 1993-11-04 CZ CZ19932352A patent/CZ286170B6/en not_active IP Right Cessation
- 1993-11-04 MX MX9306885A patent/MX9306885A/en unknown
- 1993-11-04 CA CA002102447A patent/CA2102447C/en not_active Expired - Lifetime
- 1993-11-04 PL PL93300935A patent/PL177772B1/en unknown
- 1993-11-04 TW TW082109233A patent/TW340849B/en active
- 1993-11-05 JP JP30962593A patent/JP3681764B2/en not_active Expired - Lifetime
- 1993-11-05 ZA ZA938281A patent/ZA938281B/en unknown
- 1993-11-05 HU HU9303149A patent/HU215600B/en unknown
- 1993-11-05 CN CN93114224A patent/CN1038751C/en not_active Expired - Lifetime
- 1993-11-05 NO NO934003A patent/NO309864B1/en unknown
-
1997
- 1997-08-27 GR GR970402189T patent/GR3024550T3/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970005838B1 (en) | Pharmaceutical composition containing angiotensin-converting enzyme with calcium antagonist | |
US4619916A (en) | Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications | |
YU71395A (en) | ACILLATED INSULIN ANALYSIS | |
EP0457195A3 (en) | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | |
JPH03118330A (en) | Fibrinogen receptor antagonist | |
RU96118225A (en) | CYCLOPEPTIDES, METHOD FOR THEIR OBTAINING, CONTAINING THEIR PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING IT, METHOD FOR COMBATING DISEASES, METHOD FOR OBTAINING IMMOBILIZED LIHBANDIS DISEASES | |
JPH03118333A (en) | Fibrinogen receptor antagonist | |
HK1160778A1 (en) | Pharmaceutical composition comprising an analgesic peptide | |
CA2112907C (en) | Peptide which abrogates tnf and/or lps toxicity | |
JPH03118331A (en) | Cyclic fibrinogen receptor antagonist | |
CZ277898A3 (en) | Serine proteinase inhibitors and pharmaceutical composition containing thereof | |
JPH0368599A (en) | New microprotein, its manufacture, and its use as drug | |
DE3882279T2 (en) | Cyclic anticoagulant peptide. | |
DE69426569T2 (en) | BIVALENT THROMBINE INHIBITORS | |
DE3880194T2 (en) | CYCLIC ANTICOAGULATING PEPTIDE. | |
IE914399A1 (en) | Modified hexa- and heptapeptide anaphylatoxin-receptor¹ligands | |
DE68916850T2 (en) | Anticoagulant peptide alcohols. | |
DE69133033T2 (en) | Stabilized sulfonate and sulfate derivatives of hirudin | |
HUP0003357A2 (en) | Cyclic azapeptides with angiogenic effect, pharmaceutical compositions comprising them, processes for producing thereof and their use | |
RU2000101296A (en) | CYCLIC AZEPEPTIDES WITH ANGIOGENIC ACTION | |
CA2196308A1 (en) | Peptide, bronchodilator and blood flow ameliorant | |
AU630132B2 (en) | Anticoagulant peptides | |
JPS62123198A (en) | Decapeptide | |
RU93050068A (en) | CYCLOPEPTIDES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND METHOD OF THEIR PRODUCTION, METHOD OF TREATMENT | |
AU718320B2 (en) | Peptide derivatives |